Interestingly, FGFR3 has been shown to suppress IFN-γ functions in BC cells, as the inhibition of the FGFR3 pathway reactivates downstream targets of IFN-γ (B2M, CXCL10, and PD-L1) [25, 26]. The gene discussed is FGFR3; the disease is breast cancer.